Crossmark

Combined metabolic activators therapy ameliorates liver fat in nonalcoholic fatty liver disease patients

Crossref DOI link: https://doi.org/10.15252/msb.202110459

Published Online: 2021-10-25

Published Print: 2021-10

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Zeybel, Mujdat

Altay, Ozlem

Arif, Muhammad https://orcid.org/0000-0003-2261-0881
Li, Xiangyu

Yang, Hong

Fredolini, Claudia

Akyildiz, Murat

Saglam, Burcin

Gonenli, Mehmet Gokhan https://orcid.org/0000-0003-2925-7048
Ural, Dilek https://orcid.org/0000-0003-0224-1433
Kim, Woonghee

Schwenk, Jochen M https://orcid.org/0000-0001-8141-8449
Zhang, Cheng https://orcid.org/0000-0002-3721-8586
Shoaie, Saeed

Nielsen, Jens https://orcid.org/0000-0002-9955-6003
Uhlén, Mathias

Borén, Jan https://orcid.org/0000-0003-0786-8091
Mardinoglu, Adil https://orcid.org/0000-0002-4254-6090
License Information

Version of Record valid from 2021-10-25
More Information

Publication History

Received: 2021-05-19

Accepted: 2021-09-29

Published: 2021-10-25